Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
58°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
January 23, 2024
Tickers
AZN
BMY
GILD
GRCL
Tags
FDA
Benzinga
GILD
From
Benzinga
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
January 12, 2024
Tickers
AZN
BMY
CYTK
NEWS
Tags
Reiteration
Analyst Color
Expert Ideas
From
Benzinga
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
January 11, 2024
Tickers
CYTK
NEWS
NVS
Tags
M&A
General
Movers
From
Benzinga
What's Been Happening With Cytokinetics Stock?
January 09, 2024
Tickers
CYTK
NEWS
NVS
Tags
BZ Data Project
NVS
Movers
From
Benzinga
Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today?
January 08, 2024
Tickers
CYTK
NEWS
NVS
Tags
Biotech
Large Cap
Eurasia
From
Benzinga
Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?
January 08, 2024
Tickers
EXEL
MRK
NEWS
NVS
Tags
Large Cap
Biotech
Equities
From
Benzinga
Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery
January 08, 2024
Tickers
GOOG
GOOGL
LLY
NEWS
Tags
LLY
Benzinga
GOOGL
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
January 05, 2024
Tickers
NVS
Tags
Short Sellers
Trading Ideas
Benzinga
From
Benzinga
Voyager Therapeutics Stock Tanked After-Hours - Here's Why
January 04, 2024
Tickers
NEWS
NVS
VYGR
Tags
Market News
Benzinga
Offerings
From
Benzinga
Big Players' Recent Trades in NVS Options
January 04, 2024
Tickers
NVS
Tags
Options
Benzinga
NVS
From
Benzinga
VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today
January 02, 2024
Tickers
AZN
NBIX
NVS
VYGR
Tags
VYGR
NASDAQ:VYGR,NYSE:NVS,NASDAQ:AZN,NASDAQ:NBIX
NVS
From
InvestorPlace
Why Is Gene Therapy Focused Voyager Therapeutics Stock Soaring Today?
January 02, 2024
Tickers
NEWS
NVS
VYGR
Tags
Benzinga
Market News
VYGR
From
Benzinga
Why Is Neurology Focused Cingulate Stock Trading Higher Today?
December 28, 2023
Tickers
CING
NEWS
NVS
Tags
Benzinga
FDA
Trading Ideas
From
Benzinga
Why Is Cytokinetics (CYTK) Stock Up 70% Today?
December 27, 2023
Tickers
AZN
BMY
CYTK
NVS
Tags
BMY
Today's Market
AZN
From
InvestorPlace
These 3 Big Pharma Stocks Are Making Big Plays With AI
December 22, 2023
Tickers
AZN
LLY
NVS
Tags
Market News
NVS
AZN
From
Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Tickers
CALT
MCK
NVS
RHHBY
Tags
TVTX
Market News
Benzinga
From
Benzinga
Fusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside
December 20, 2023
Tickers
AZN
FUSN
NVS
Tags
Initiation
Analyst Color
Expert Ideas
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 20, 2023
Tickers
NVS
Tags
Short Ideas
BZI/SHORTHIST
Market News
From
Benzinga
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
December 19, 2023
Tickers
LNTH
NVS
PNT
Tags
Market News
Analyst Ratings
Trading Ideas
From
Benzinga
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
December 17, 2023
Tickers
ECX
FSR
FTRE
GELYF
Tags
LLY
ECX
Market News
From
InvestorPlace
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Tickers
MRK
NVS
Tags
FDA
Benzinga
MRK
From
Benzinga
Novartis' Newly FDA-Approved Rare Blood Disorder Drug Aces Phase 3 Study In Ultra Rare Kidney Failure Disease
December 11, 2023
Tickers
NVS
Tags
Market News
Benzinga
Large Cap
From
Benzinga
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
December 10, 2023
Tickers
BMY
GILD
NVS
Tags
Recent Press Releases
BMY
Market News
From
Motley Fool
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Tickers
NVS
Tags
Benzinga
FDA
Market News
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 01, 2023
Tickers
NVS
Tags
Trading Ideas
Short Sellers
Benzinga
From
Benzinga
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
Tickers
BMY
GILD
JNJ
NVS
Tags
BMY
Health Care
Large Cap
From
Benzinga
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
November 28, 2023
Tickers
BMY
CABA
GILD
GRCL
Tags
BMY
GRCL
CABA
From
MarketWatch
3 Healthcare Stocks to Pick Up Before the Year-End Rally
November 28, 2023
Tickers
BSX
NVS
UNH
Tags
Stocks to Buy
Market News
NYSE:UNH,NYSE:BSX,NYSE:NVS
From
InvestorPlace
Novartis Outlines Pure-Play Strategy Progress After Generics Business Spin-Off
November 28, 2023
Tickers
NVS
Tags
Health Care
Large Cap
Biotech
From
Benzinga
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
November 16, 2023
Tickers
CVRX
JNJ
LEGN
NVS
Tags
JNJ
Market News
NVS
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.